PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401797
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401797
Tissue Engineering Market size was valued at USD 15,120 Million in 2022, expanding at a CAGR of 15.1% from 2023 to 2030.
Tissue engineering encompasses a blend of biology, engineering, and materials science to craft biological replacements that restore, maintain, or enhance tissue function. Its primary goal is constructing functional three-dimensional tissues and organs using biomaterials, cells, and biochemical factors within controlled environments. This process commonly involves procuring cells either from the patient or donors, cultivating them in laboratories, and placing them on supportive structures crafted from biocompatible materials called scaffolds. These scaffolds act as a framework for cells to proliferate and form organized, functional tissues. Furthermore, growth factors and bioactive molecules are often utilized to prompt cell growth, differentiation, and tissue creation. Tissue engineering shows potential across various fields such as regenerative medicine, crafting artificial organs for transplantation, developing models for drug testing, and studying diseases under controlled conditions. Its objective is to tackle tissue damage, organ failure, and medical conditions by offering innovative solutions to repair or replace impaired tissues or organs.
Tissue Engineering Market- Market Dynamics
Rise in chronic diseases like cardiovascular conditions, diabetes, and orthopedic disorders to propel market demand
The rise in chronic diseases like cardiovascular conditions, diabetes, and orthopedic disorders has fueled the need for tissue engineering solutions capable of repairing or substituting damaged tissues. Notably, tissue engineering has made substantial strides owing to advancements in stem cell research, 3D bioprinting, biomaterials, as well as gene editing techniques. These advancements have enabled the creation of intricate and operational tissues. Tissue regeneration technology is gaining traction due to its efficacy and minimal rejection rates, leading to an increasing number of regeneration treatments being conducted. Presently, ongoing preclinical research concentrates on employing tissue-engineered vascular grafts for cardiovascular surgeries and treatment. Additionally, successful implantation of tissue-engineered bladders outside the patient's body has been observed. Technological progress in 3D tissue engineering, like substituting embryo cells with stem cells, organ-on-a-chip technology, and the use of efficient 3D bioprinters for designing in vitro implants, is expected to spur growth. Moreover, increased governmental funding for medical and academic research endeavors is projected to further fuel the tissue engineering market. For instance, in January 2023, Sartorius, a biopharmaceutical equipment supplier, acquired a 10% stake in BICO, a cutting-edge 3D bioprinting firm, for USD 49.91 million. Both companies have announced collaborative plans focusing on research and development initiatives aimed at creating digital solutions for cell line development workflows.
Tissue Engineering Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.1% over the forecast period (2023-2030)
Based on material type segmentation, biological recognition was predicted to show maximum market share in the year 2022
Based on application segmentation, Orthopedic muscoskeletal and spine was the leading type in 2022
On the basis of region, North America was the leading revenue generator in 2022
The Global Tissue Engineering Market is segmented on the basis of Material type, Application, End User, and Region.
The market is divided into three categories based on material type: Synthetic, Biological, Others. Based on material type, the biological segment asserted its dominance within the market landscape in 2022. The advancement of tissue engineering and biomedical devices, which aim to naturally enhance tissue regeneration for repairing deteriorating bodily functions, heavily relies on biomaterials. In vitro production of neo-tissues, resembling the body's fundamental components, utilizes biologically derived components. Moreover, these materials facilitate tissue regeneration by selectively delivering and releasing specific chemokines at sites of damage, while also providing temporary support matrices akin to tissue, which degrade naturally and operate functionally.
The market is divided into six categories based on Application: Dermal, Orthopedic muscoskeletal and spine, Dental, Neurology, Regenerative medicine research and others. Based on application, the orthopedics, musculoskeletal, and spine segment dominated the revenue share in 2022 due to the escalating prevalence of musculoskeletal disorders. Tissue engineering has emerged as a critical therapeutic option for orthopedic surgeons dealing with various musculoskeletal diseases, spanning from meniscal deficiencies in young athletes to osteochondral irregularities in the glenohumeral joint. Based on the World Health Organization (WHO), rheumatoid arthritis impacts over 23 million people globally. Another study, published in May 2021, indicated 460 cases of rheumatoid arthritis per 100,000 individuals worldwide between 1980 and 2019.
Tissue Engineering Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
The tissue engineering market is actively embracing diverse strategies to revolutionize regenerative medicine and personalized healthcare. Companies are focusing on innovative approaches using biomaterials, scaffolds, and bioactive molecules to fabricate functional tissues and organs. Cutting-edge techniques like 3D bioprinting enable precise construction of intricate tissues for transplantation and research. Furthermore, research initiatives emphasize stem cell technology and gene editing for regenerative therapies, aiming to tackle organ failure and tissue damage. Collaborations between academia, biotech firms, and healthcare institutions drive research and development, while adherence to regulations and ethical considerations shapes market growth. Overall, the strategies of the tissue engineering market revolve around pioneering solutions to meet the growing demand for effective regenerative treatments and organ replacements.
In January 2023, according to the independent German scientific organization, BioMed X and AbbVie have expanded their research collaboration. After an initial cooperative effort on Alzheimer's illness at the BioMed X Institute in Heidelberg, Germany, the new cooperation in the United States will concentrate on immunology and tissue engineering.
In April 2022, Organogenesis Inc, a global leader in regenerative medicine, unveiled its latest advanced wound care research on various product lines like Affinity, PuraPly AM, NuShield, Novachor, Apligraf, along with Organogenesis Physician Solutions. This showcase occurred during the 2022 Symposium on Advanced Wound Care (SAWC) Spring Conference, held from April 6 to April 10, 2022, in Phoenix, Arizona.
The scope of this report covers the market by its major segments, which include as follows: